CN102919560B - 提高奶牛繁殖力的功能性预混料 - Google Patents
提高奶牛繁殖力的功能性预混料 Download PDFInfo
- Publication number
- CN102919560B CN102919560B CN201210474727.4A CN201210474727A CN102919560B CN 102919560 B CN102919560 B CN 102919560B CN 201210474727 A CN201210474727 A CN 201210474727A CN 102919560 B CN102919560 B CN 102919560B
- Authority
- CN
- China
- Prior art keywords
- ion
- vitamin
- cow
- feed grade
- source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000283690 Bos taurus Species 0.000 title abstract description 125
- 230000035558 fertility Effects 0.000 title abstract 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000000463 material Substances 0.000 claims abstract description 27
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims abstract description 20
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 17
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 17
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 17
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 17
- 239000011719 vitamin A Substances 0.000 claims abstract description 17
- 229940045997 vitamin a Drugs 0.000 claims abstract description 17
- 239000011709 vitamin E Substances 0.000 claims abstract description 15
- 229940046009 vitamin E Drugs 0.000 claims abstract description 15
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 14
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 14
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 claims abstract description 12
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims abstract description 12
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 11
- 159000000007 calcium salts Chemical class 0.000 claims abstract description 10
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 claims abstract description 10
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims abstract description 10
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims abstract description 10
- 239000011790 ferrous sulphate Substances 0.000 claims abstract description 10
- 235000003891 ferrous sulphate Nutrition 0.000 claims abstract description 10
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims abstract description 10
- 235000019341 magnesium sulphate Nutrition 0.000 claims abstract description 10
- 239000011702 manganese sulphate Substances 0.000 claims abstract description 10
- 235000007079 manganese sulphate Nutrition 0.000 claims abstract description 10
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims abstract description 10
- 239000011781 sodium selenite Substances 0.000 claims abstract description 10
- 235000015921 sodium selenite Nutrition 0.000 claims abstract description 10
- 229960001471 sodium selenite Drugs 0.000 claims abstract description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000011701 zinc Substances 0.000 claims abstract description 5
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 5
- -1 iron ion Chemical class 0.000 claims description 75
- 239000008267 milk Substances 0.000 claims description 71
- 210000004080 milk Anatomy 0.000 claims description 71
- 235000013336 milk Nutrition 0.000 claims description 71
- 239000000843 powder Substances 0.000 claims description 20
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 14
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 14
- 239000011575 calcium Substances 0.000 claims description 14
- 229910052791 calcium Inorganic materials 0.000 claims description 14
- 239000011669 selenium Substances 0.000 claims description 14
- 229910052711 selenium Inorganic materials 0.000 claims description 14
- 229940091258 selenium supplement Drugs 0.000 claims description 14
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 12
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims description 12
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 12
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 claims description 12
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims description 12
- 229910001424 calcium ion Inorganic materials 0.000 claims description 12
- 229910001429 cobalt ion Inorganic materials 0.000 claims description 12
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 claims description 12
- 229910001431 copper ion Inorganic materials 0.000 claims description 12
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims description 12
- 229940006461 iodide ion Drugs 0.000 claims description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
- 229910052742 iron Inorganic materials 0.000 claims description 12
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 12
- 229910001437 manganese ion Inorganic materials 0.000 claims description 12
- 229910001414 potassium ion Inorganic materials 0.000 claims description 12
- 229930003316 Vitamin D Natural products 0.000 claims description 10
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 10
- 235000019166 vitamin D Nutrition 0.000 claims description 10
- 239000011710 vitamin D Substances 0.000 claims description 10
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 10
- 229940046008 vitamin d Drugs 0.000 claims description 10
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 9
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 9
- 229940099596 manganese sulfate Drugs 0.000 claims description 9
- CUXQLKLUPGTTKL-UHFFFAOYSA-M microcosmic salt Chemical compound [NH4+].[Na+].OP([O-])([O-])=O CUXQLKLUPGTTKL-UHFFFAOYSA-M 0.000 claims description 9
- 229940110280 zinc methionine Drugs 0.000 claims description 9
- CNMFGFBWPBBGKX-SCGRZTRASA-L zinc;(2s)-2-amino-4-methylsulfanylbutanoate Chemical compound [Zn+2].CSCC[C@H](N)C([O-])=O.CSCC[C@H](N)C([O-])=O CNMFGFBWPBBGKX-SCGRZTRASA-L 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 8
- 229940072033 potash Drugs 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- 235000015320 potassium carbonate Nutrition 0.000 claims description 8
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 6
- 235000005152 nicotinamide Nutrition 0.000 claims description 6
- 239000011570 nicotinamide Substances 0.000 claims description 6
- 229960003966 nicotinamide Drugs 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 abstract description 18
- 229930003231 vitamin Natural products 0.000 abstract description 18
- 235000013343 vitamin Nutrition 0.000 abstract description 18
- 239000011782 vitamin Substances 0.000 abstract description 18
- 239000011573 trace mineral Substances 0.000 abstract description 10
- 235000013619 trace mineral Nutrition 0.000 abstract description 10
- 208000021129 Postpartum disease Diseases 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 abstract description 3
- 235000013734 beta-carotene Nutrition 0.000 abstract description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 abstract description 3
- 239000011648 beta-carotene Substances 0.000 abstract description 3
- 229960002747 betacarotene Drugs 0.000 abstract description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 abstract description 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N pantothenic acid Chemical compound OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 abstract 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- 239000011665 D-biotin Substances 0.000 abstract 1
- 235000000638 D-biotin Nutrition 0.000 abstract 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 1
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 229930003471 Vitamin B2 Natural products 0.000 abstract 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 abstract 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical class [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 abstract 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019164 vitamin B2 Nutrition 0.000 abstract 1
- 239000011716 vitamin B2 Substances 0.000 abstract 1
- 235000005282 vitamin D3 Nutrition 0.000 abstract 1
- 239000011647 vitamin D3 Substances 0.000 abstract 1
- 229940021056 vitamin d3 Drugs 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 36
- 201000010099 disease Diseases 0.000 description 28
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 28
- 150000003722 vitamin derivatives Chemical class 0.000 description 17
- 235000013365 dairy product Nutrition 0.000 description 12
- 230000014759 maintenance of location Effects 0.000 description 12
- 230000012173 estrus Effects 0.000 description 10
- 210000000003 hoof Anatomy 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 230000001850 reproductive effect Effects 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 7
- 208000004145 Endometritis Diseases 0.000 description 7
- 230000001488 breeding effect Effects 0.000 description 7
- 230000035606 childbirth Effects 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 206010033799 Paralysis Diseases 0.000 description 6
- 238000009395 breeding Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 208000004396 mastitis Diseases 0.000 description 6
- 208000025661 ovarian cyst Diseases 0.000 description 6
- 208000009774 Follicular Cyst Diseases 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000035935 pregnancy Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 201000006381 corpus luteum cyst Diseases 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 208000017443 reproductive system disease Diseases 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 210000002394 ovarian follicle Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 206010021135 Hypovitaminosis Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 210000004246 corpus luteum Anatomy 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000005965 immune activity Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000008986 qingzhen Substances 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 238000000528 statistical test Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 206010059410 Faecaluria Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LTGPFZWZZNUIIK-LURJTMIESA-N Lysol Chemical compound NCCCC[C@H](N)CO LTGPFZWZZNUIIK-LURJTMIESA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010062936 Placenta Accreta Diseases 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011981 development test Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000008011 embryonic death Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Fodder In General (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210474727.4A CN102919560B (zh) | 2012-11-21 | 2012-11-21 | 提高奶牛繁殖力的功能性预混料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210474727.4A CN102919560B (zh) | 2012-11-21 | 2012-11-21 | 提高奶牛繁殖力的功能性预混料 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102919560A CN102919560A (zh) | 2013-02-13 |
CN102919560B true CN102919560B (zh) | 2014-06-04 |
Family
ID=47634608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210474727.4A Active CN102919560B (zh) | 2012-11-21 | 2012-11-21 | 提高奶牛繁殖力的功能性预混料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102919560B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104757317B (zh) * | 2015-04-01 | 2018-06-05 | 中粮饲料有限公司 | 一种浓缩料及其应用 |
CN106260620B (zh) * | 2016-08-12 | 2019-11-08 | 广东溢多利生物科技股份有限公司 | 一种新型反刍动物专用生物制剂产品及其制备方法 |
CN107079833A (zh) * | 2017-07-03 | 2017-08-22 | 安徽省农业科学院畜牧兽医研究所 | 一种防治大别山母牛隐性发情的方法 |
CN110199949A (zh) * | 2019-07-02 | 2019-09-06 | 凤台雁福农业发展有限公司 | 一种母牛诱导发情方法 |
CN111184127A (zh) * | 2019-12-18 | 2020-05-22 | 内蒙古自治区农牧业科学院 | 保护反刍动物瘤胃上皮通透性的营养活性物质调控剂 |
CN112772786A (zh) * | 2021-02-02 | 2021-05-11 | 北京中秾鼎鑫农牧科技有限公司 | 一种繁殖母牛功能性预混料 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1217588C (zh) * | 2002-04-26 | 2005-09-07 | 上海光明乳业股份有限公司 | 干奶牛预混料 |
CN1439284A (zh) * | 2003-02-19 | 2003-09-03 | 长春市昌大实业有限公司 | 奶牛饲料及生产工艺 |
CN1723792A (zh) * | 2004-07-23 | 2006-01-25 | 陕西杨凌富仕特饲料有限公司 | 一种专用于奶牛的预混料 |
CN100553472C (zh) * | 2006-04-20 | 2009-10-28 | 新疆维吾尔自治区畜牧科学院畜牧科学研究所 | 增加奶牛产奶量的精饲料复合添加剂 |
CN101810255B (zh) * | 2010-04-07 | 2012-06-27 | 北京东方天合生物技术有限责任公司 | 一种新型泌乳牛干奶期复合预混合饲料及其生产方法 |
CN102599382B (zh) * | 2012-03-29 | 2013-06-26 | 常熟市润丰农业有限公司 | 一种饲料添加剂 |
-
2012
- 2012-11-21 CN CN201210474727.4A patent/CN102919560B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102919560A (zh) | 2013-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102919560B (zh) | 提高奶牛繁殖力的功能性预混料 | |
CN101278706B (zh) | 后备母猪、催情母猪及种公猪饲料 | |
CN103284002B (zh) | 一种母猪围产期浓缩饲料 | |
CN101669587B (zh) | 一种种猪营养补充剂及其制备方法 | |
CN102038114B (zh) | 一种空怀母猪用浓缩料 | |
CN100429991C (zh) | 仔猪断奶饲料 | |
CN101785529B (zh) | 奶牛围产后期专用复合预混料及其应用 | |
CN104431558B (zh) | 一种母猪配种前使用的浓缩饲料 | |
CN105104888A (zh) | 一种猪饲料 | |
CN103156071A (zh) | 硫酸钾镁及含有硫酸钾镁的混合物作为动物饲料添加剂的应用 | |
Campanile et al. | Protein nutrition and nitrogen balance in buffalo cows | |
CN102499323B (zh) | 一种基于营养方式促进产后奶牛发情排卵的精料补充饲料 | |
Sarwar et al. | Influence of varying level of sodium bicarbonate on milk yield and its composition in early lactating Nili Ravi buffaloes | |
CN103238754B (zh) | 一种用于母猪快速分娩及产后康复的复合预混料及其制备工艺 | |
CN108813141A (zh) | 一种提高种猪繁殖性能的饲料调控剂 | |
CN103609867B (zh) | 促进种畜禽生长繁殖的复合预混合饲料 | |
CN106615812B (zh) | 一种促进母猪生长繁殖的预混剂及其制备方法与应用 | |
CN104366148A (zh) | 一种后备母猪饲料添加剂及其应用 | |
CN104543403B (zh) | 专用于肉牛育肥增重的维生素及矿物质营养复合防病制剂 | |
CN105961853A (zh) | 一种适用于西部地区放牧牛的富含锌元素的营养舔砖 | |
CN107183385B (zh) | 一种提高哺乳母猪生产性能的饲料添加剂及其制备方法与应用 | |
CN111820330A (zh) | 一种提高哺乳仔猪发育的母猪饲料 | |
RU2405555C1 (ru) | Способ профилактики лактационного истощения у высокопродуктивных коров | |
CN103349181A (zh) | 增加母猪窝产仔数延长种用期的预混料 | |
CN108850615A (zh) | 一种母猪妊娠后期饲料以及饲养方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160215 Address after: 550014 Guizhou Province, Guiyang Baiyun District of Baba Ao Patentee after: Guiyang gold full ship Feed Co.,Ltd. Address before: 550005 Guiyang Longdong fort, old Li Po Patentee before: GUIZHOU INSTITUTE OF ANIMAL HUSBANDRY AND VETERINARY MEDICINE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20240301 Address after: 550000, 17th Floor, Building 11, Business District, Guiyang International Financial Center Phase I, Changling North Road, Guanshanhu District, Guiyang City, Guizhou Province Patentee after: Guizhou Modern Fisheries Group Co.,Ltd. Country or region after: China Address before: 550014 baba'ao, Baiyun District, Guiyang City, Guizhou Province Patentee before: Guiyang gold full ship Feed Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |